Preliminary study on pH-sensitive lipid bilayer-coated mesoporous silica nanoparticles as a novel drug carrier for antitumor drug

Yaoxue Xuebao

Volumn 48, Issue 2, 2013, Pages 291-297

  Li, Fei Fei ^a,b   Zhang, Xin Xin ^b   Guo, Shi Yan ^b   Gan, Yong ^b   Li, Juan ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Core shell nanoparticle; Drug carrier; Irinotecan; Mesoporous silica nanoparticle; pH sensitive

Indexed keywords

DRUG CARRIER; IRINOTECAN; LIPID BILAYER COATED MESOPOROUS SILICA NANOPARTICLE; NANOPARTICLE; SILICON; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; DRUG CYTOTOXICITY; DRUG RELEASE; DRUG STRUCTURE; DRUG UPTAKE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LIPID BILAYER; PARTICLE SIZE; PH;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL PROLIFERATION; DRUG CARRIERS; HUMANS; HYDROGEN-ION CONCENTRATION; LIPID BILAYERS; MCF-7 CELLS; NANOPARTICLES; PARTICLE SIZE; POROSITY; SILICON DIOXIDE;

EID: 84877095876     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Ashley CE, Carnes EC, Epler KE, et al. Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers [J]. ACS Nano, 2012, 6: 2174-2188.
2. Ye GF, Gupta A, DeLuca R, et al. Bilayer disruption and liposome restructuring by a homologous series of small Arg-rich synthetic peptides [J]. Colloids Surf B Biointerfaces, 2010, 76: 76-81.
3. Chen X, Wang XH, Wang YS, et al. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide [J]. J Control Release, 2010, 145: 17-25.
4. Marcucci F, Corti A. How to improve exposure of tumor cells to drugs-promoter drugs increase tumor uptake and penetration of effector drugs [J]. Adv Drug Deliv Rev, 2012, 64: 53-68.
5. Lee CH, Cheng SH, Wang YJ, et al. Near-infrared mesoporous silica nanoparticles for optical imaging: characterization and in vivo biodistribution [J]. Adv Funct Mater, 2009, 19: 215-222.
6. Lai CY, Trewyn BG, Jeftinija DM, et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules [J]. J Am Chem Soc, 2003, 125: 4451-4459.
7. Gao Y, Chen Y, Ji X, et al. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles [J]. ACS Nano, 2011, 5: 9788-9798.
8. Slowing II, Vivero-Escoto JL, Wu CW, et al. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers [J]. Adv Drug Deliv Rev, 2008, 60: 1278-1288.
9. Liu JW, Stace-Naughton A, Jiang XM, et al. Porous nanoparticle supported lipid bilayers (protocells) as delivery vehicles [J]. J Am Chem Soc, 2009, 131: 1354-1355.
10. He QJ, Shi JL, Chen F, et al. An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles [J]. Biomaterials, 2010, 31: 3335-3346.
11. Lu J, Liong M, Sherman S, et al. Mesoporous silica nanoparticles for cancer therapy: energy-dependent cellular uptake and delivery of paclitaxel to cancer cells [J]. Nanobiotechnology, 2007, 3: 89-95.
12. Yang Y, Song WX, Wang AH, et al. Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers [J]. Phys Chem Chem Phys, 2010, 12: 4418-4422.
13. Liu JW, Jiang XM, Ashley C, et al. Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery [J]. J Am Chem Soc, 2009, 131: 7567-7569.
14. Shi MJ, Hsu CY, Huang LY, et al. Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells [J]. J Control Release, 2011, 152: 418-425.
15. Bellavancea MA, Poirierb MB, Fortin D. Uptake and intracellular release kinetics of liposome formulations in glioma cells [J]. Int J Pharm, 2010, 395: 251-259.
16. Johnston APR, Kamphuis MMJ, Such GK, et al. Targeting cancer cells: controlling the binding and internalization of antibody-functionalized capsules [J]. ACS Nano, 2012, 6: 6667-6674.
17. Zhou YM, Wu XP, Zeng Li, et al. In vitro anti-tumor effect of methotrexate modified by peptide [J]. Acta Pharm Sin, 2012, 47: 452-458.
18. Joo JB, Park JC, Yi JH. Preparation of polyelectrolyte-functionalized mesoporous silicas for the selective adsorption of anionic dye in an aqueous solution [J]. J Hazard Mater, 2009, 168: 102-107.
19. Lin HM, Qu FY, Wu X, et al. Mixed surfactants-directed the mesoporous silica materials with various morphologies and structures [J]. J Solid State Chem, 2011, 184: 1415-1420.
20. Chen F, Zhu YC. Chitosan enclosed mesoporous silica nanoparticles as drug nano-carriers: sensitive response to the narrow pH range [J]. Microporous Mesoporous Mater, 2012, 150: 83-89.
21. Zhang YZ, Zhi ZZ, Jiang TY, et al. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan [J]. J Control Release, 2010, 145: 257-263.
22. Ashley CE, Carnes EC, Phillips GK, et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporousparticle-supported lipid bilayers [J]. Nat Mater, 2011, 10: 389-397.